Quantification, identification, and relevance of anti-human leukocyte antigen antibodies formed in association with the berlin heart ventricular assist device in children

Transplantation

Volumn 95, Issue 12, 2013, Pages 1542-1547

  O'Connor, Matthew J ^a   Harville, Terry O ^b   Rhodes Clark, Bobbie ^c   Pye, Sherry E ^a   Knecht, Kenneth R ^a   Imamura, Michiaki ^c   Frazier, Elizabeth A ^a   Morrow, W Robert ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Human leukocyte antibodies; Pediatrics; Ventricular assist device

Indexed keywords

ANTIBODY; HUMAN LEUKOCYTE ANTIGEN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; INFANT; MALE; MEDICAL DEVICE COMPLICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIZATION; VENTRICULAR ASSIST DEVICE;

CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HLA ANTIGENS; HUMANS; INFANT; ISOANTIBODIES; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84880109498     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182925242     Document Type: Article

References (25)

1. Blume ED, Naftel DC, Bastardi HJ, et al. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation 2006; 113: 2313.
2. Morales DL, Almond CS, Jaquiss RD, et al. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant 2011; 30: 1.
3. Fraser CD, Jaquiss RDB, Rosenthal DN, et al. Prospective trial of a pediatric ventricular assist device. N Engl J Med 2012; 367: 532.
4. Arrington CB, Shaddy RE. Immune response to allograft implantation in children with congenital heart defects. Exp Rev Cardiovasc Ther 2006; 4: 695.
5. Moazami N, Itescu S, Williams MR, et al. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant 1998; 17: 876.
6. George I, Colley P, Russo MJ, et al. Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg 2008; 135: 1372.
7. Rossano JW, Morales DLS, Zafar F, et al. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2010; 140: 694.
8. McKenna DH Jr, Eastlund T, Segall M, et al. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant 2002; 21: 1218.
9. Joyce DL, Southard RE, Torre-Amione G, et al. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. JHeart Lung Transplant 2005; 24: 2054.
10. John R, Lietz K, Schuster M, et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 2003; 125: 578.
11. O'Connor MJ, Menteer J, Chrisant MR, et al. Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation. J Heart Lung Transplant 2010; 29: 109.
12. Yang J, Schall C, Smith D, et al. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex. J Heart Lung Transplant 2009; 28: 123.
13. Massad MG, Cook DJ, Schmitt SK, et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 1997; 64: 1120.
14. Gonzalez-Stawinski GV, Atik FA, McCarthy PM, et al. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. Transplant Proc 2005; 37: 1349.
15. DeNofrio D, Rho R, Morales FJ, et al. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation. Transplantation 2000; 69: 814.
16. Itescu S, John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg 2003; 75: S58.
17. Schuster M, Kocher A, John R, et al. B-cell activation and allosen-sitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum Immunol 2002; 63: 211.
18. Drakos SG, Kfoury AG, Kotter JR, et al. Prior human leukocyte antigen allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant 2009; 28: 838.
19. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous flow left ventricular assist device. N Engl J Med 2009; 361: 2241.
20. Mahle WT, Tresler MA, Edens RE, et al. Allosensitization and outcomes in pediatric heart transplantation. J Heart Lung Transplant 2011; 30: 1221.
21. Holt DB, Lublin DM, Phelan DL, et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007; 26: 876.
22. Pollock-BarZiv SM, den Hollander N, Ngan B, et al. Pediatric heart transplantation in human leukocyte antigen-sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation 2007; 116: I-172.
23. Drakos SG, Kfoury AG, Long JW, et al. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg 2006; 82: 889.
24. Morrow WR, Frazier EA, Mahle WT, et al. Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients. Transplantation 2012; 93: 319.
25. Shakar SF, Lindenfeld J. Editorial commentary: "All that glitters is not gold". J Heart Lung Transplant 2012; 31: 441.